Wisp Expands Menopause Solutions and Launches Weight Care Vertical for Women
Wisp, the leading women’s telehealth company in the U.S. dedicated to sexual and reproductive health, has announced a significant expansion of its services to better support women throughout their healthcare journeys. Serving over 1.2 million patients, the company is launching a new weight care vertical that provides personalized online healthcare consultations. This initiative focuses on helping women facing hormonal imbalances related to perimenopause, menopause, Polycystic Ovary Syndrome (PCOS), and endometriosis.
As part of this launch, Wisp introduces its first exclusive over-the-counter weight care capsules aimed at promoting metabolic health. “Wisp is committed to providing sustainable support for women’s weight loss journeys, addressing a critical yet often overlooked aspect of women’s health,” said Monica Cepak, CEO of Wisp. “As discussions around obesity evolve, we recognize that underlying conditions—especially hormonal imbalances linked to perimenopause and menopause—are frequently under-researched, underdiagnosed, and undertreated. With these new offerings, we’re proud to expand access to comprehensive care, providing tailored solutions for every woman at every price point.”
Starting today, patients can request prescription GLP-1 medications and over-the-counter supplements through pharmacy pickup or free discreet delivery. The process begins with a digital health consultation on Wisp’s platform, which a licensed medical provider reviews. If deemed safe and suitable, patients can start the program. Wisp’s weight care program includes educational content and monthly check-ins, along with the following options:
- Semaglutide (Branded FDA-Approved Wegovy®) Subcutaneous Injectable Medication
- Compounded Semaglutide Subcutaneous Injectable Medication
- Compounded Sublingual Semaglutide
- Metabolic Support & GLP-1 Boost Capsules
Key ingredients in the weight care capsules include:
- Eriomin®: May increase GLP-1 levels, support insulin function, and promote healthy blood glucose levels.
- Actiz!ng™ (Black Ginger Extract): Clinically tested to help reduce abdominal fat and significantly increase calorie burning.
- Glucovantage® Dihydroberberine: Five times more bioavailable than berberine, it may support healthier body composition and lower blood sugar levels.
- PoZibio™ (Lactobacillus paracasei): May reduce gut inflammation and support healthy aging and metabolic function.
In addition to the weight care launch, Wisp is enhancing its menopause solutions to better serve the more than 2 million women experiencing menopause annually. Recognizing the unmet needs in this area, Wisp is expanding its perimenopause and menopause offerings with new prescription Estriol Face Cream and hormone replacement therapy treatments, including Transdermal Estradiol Patches, Oral Micronized Progesterone Capsules, and Oral Provera Tablets.
Wisp’s expansion into weight management is part of a broader vision to support women at every stage of life. The brand plans to strengthen its strategic partnerships and expand its offerings to include more at-home diagnostics and treatment options across STI, fertility, menopause, and weight care categories later this year.
ABOUT WISP:
Wisp is a women’s health company on a mission to make sexual and reproductive healthcare more inclusive, cost-effective, and accessible. Available in all 50 states, Wisp provides discreet treatments online with a comprehensive selection of products and telehealth services, including prescription medication, OTC prevention, at-home testing and more. Wisp is a growing and profitable company and is majority-owned by WELL Health Technologies Corp. To learn more, please visit hellowisp.com or follow @hellowisp on Facebook, Instagram, TikTok and YouTube.
